The trading price of AMMO, Inc. (NASDAQ:POWW) closed higher on Monday, Feb 22, closing at $7.7, 6.49% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $7.75 and $8.68. The company’s P/E ratio in the trailing 12-month period was 0, while its 5Y monthly beta was -0.28. In examining the 52-week price action we see that the stock hit a 52-week high of $9.95 and a 52-week low of $1. Over the past month, the stock has gained 38.98% in value.
On the technical side, indicators suggest POWW has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned POWW a recommendation rating is 1. Out of them, 1 rate it a Hold, while none recommend Buy, whereas none assign an Outperform rating. None analyst(s) have tagged AMMO, Inc. (POWW) as Underperform, while not any of them advise Sell. Analysts have rated the stock Hold, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
To see how AMMO, Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: POWW stock’s performance was +6.49% in the latest trading, and +622.47% in the past year, while Bristol-Myers Squibb Company (BMY) has traded +0.64% on the day and positioned -7.07% lower than it was a year ago. Another comparable company Amgen Inc (AMGN) saw its stock close -0.09% lower in the most recent trading session but was up +3.9% in a year. Furthermore, Gilead Sciences Inc (GILD) showed an increase of 6.49% on the day while its price kept rising at 622.47% over the past year. AMMO, Inc. has a P/E ratio of 0, compared to Bristol-Myers Squibb Company’s 0 and Amgen Inc’s 18.8. Also in last trading session, the S&P 500 Index has soared -0.77%, while the Dow Jones Industrial also saw a positive session, up +0.09% on the day.
An evaluation of the daily trading volume of AMMO, Inc. (NASDAQ:POWW) indicates that the 3-month average is 3.27 Million. However, this figure has declined over the past 10 days to an average of 3.01 Million.
Currently, records show that 68.68 Million of the company’s shares remain outstanding. According to Thomson Reuters data, insiders hold 22.43% of outstanding shares, whereas institutions hold 0.01%. The stats also highlight that short interest as of January 28, 2021, stood at 259.37 Million shares, resulting in a short ratio of 0.06 at that time. From this, we can conclude that short interest is 0.42% of the company’s total outstanding shares. It is noteworthy that short shares in January were up slightly from the previous month’s figure, which was 129.39 Million. However, since the stock’s price has seen +148.48% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.